STRO vs WELL
Sutro Biopharma (STRO) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
STRO currently screens at market cap $470.8M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the STRO and WELL stock pages for the full models.
Not investment advice.